Mounjaro Injection, Solution
Product Images NDC 50090-8025

Product Visual Gallery

This gallery contains 64 technical images submitted to the FDA as part of the official labeling for Mounjaro (NDC 50090-8025). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500908025)

MOUNJARO 2.5 mg/.5 mL tirzepatide injection, solution in prefilled pen packaging. The label includes dosage instructions for subcutaneous administration, storage conditions to protect from light and store at 46 degrees Fahrenheit, and the labeler A-S Medication Solutions, Libertyville, Illinois. The product NDC is 50090-8025-0.*

FDA Label Image

Figure (Logo)

FDA Label Image

Figure (Moun Pen Ifu 1 V3)

MOUNJARO 2.5 mg/.5 mL injection, solution for subcutaneous use in a prefilled pen injector. The pen has a transparent cap, gray dose button, white body with a small window displaying dose level, and a purple end cap. Labeler is A-S Medication Solutions.*

FDA Label Image

Figure (Moun Pen Ifu 10 V2)

Illustration showing the gray plunger component inside a clear injection needle cap. The focus is on the internal mechanism of the cap, highlighting the position of the gray plunger within the transparent plastic housing.*

FDA Label Image

Figure (Moun Pen Ifu 2 V2)

Illustration of a MOUNJARO (tirzepatide) subcutaneous injection pen. The diagram labels the pen's components including the purple injection button at the top, lock ring, indicator, lock or unlock mechanism, medicine reservoir, clear base, and gray base cap at the needle end.*

FDA Label Image

Figure (Moun Pen Ifu 3 V2)

An illustration showing a subcutaneous injection device for MOUNJARO (tirzepatide), highlighting the location where the expiration date is displayed on the pen. The image focuses on guiding the user to find the expiration date on the injection pen.*

FDA Label Image

Figure (Moun Pen Ifu 4a V1)

An instructional illustration showing recommended subcutaneous injection sites for MOUNJARO (tirzepatide) injection solution. The highlighted areas include the abdomen around the navel and the front thigh regions as suitable injection sites.*

FDA Label Image

Figure (Moun Pen Ifu 4b V1)

An instructional illustration showing the back view of a human body with purple shaded areas on both upper arms, indicating recommended injection sites for subcutaneous administration.*

FDA Label Image

Figure (Moun Pen Ifu 5 V2)

An instructional diagram showing how to remove the gray base cap from a MOUNJARO (tirzepatide) injection pen. The graphic depicts a hand holding the pen with a clear base, with an arrow indicating the removal of the gray base cap from the bottom of the pen.*

FDA Label Image

Figure (Moun Pen Ifu 6 V2)

Illustration showing a person administering a subcutaneous injection in the abdominal area using a pen injector device. The image demonstrates proper hand positioning for injecting a dose, consistent with subcutaneous injection instructions for medications like MOUNJARO (tirzepatide) injection.*

FDA Label Image

Figure (Moun Pen Ifu 7 V2)

An instructional illustration showing a hand holding an injection pen, with an arrow indicating a twisting or unlocking motion near the pen cap and a padlock icon transitioning from locked to unlocked, suggesting how to prepare the device for use.*

FDA Label Image

Figure (Moun Pen Ifu 8 V2)

An instructional illustration showing a person administering a MOUNJARO (tirzepatide) 2.5 mg/0.5 mL subcutaneous injection into the abdomen using a prefilled injection pen. The image focuses on hand positioning and injection site technique.*

FDA Label Image

Figure (Moun Pen Ifu 9 V2)

An illustration showing a close-up view of a syringe or pen needle tip with a focus on a gray plunger inside the device, labeled with an arrow indicating the plunger component.*

FDA Label Image

Figure (Moun Qr)

FDA Label Image

Structural Formula (Moun Uspi Chem Struc)

Chemical structure diagram of tirzepatide, the active ingredient in MOUNJARO injection. The structure shows the detailed amino acid sequence and molecular connections of the peptide drug.*

FDA Label Image

Figure 1 (Moun Uspi F1 V1)

A line graph depicting insulin levels (mIU/L) over time (minutes) with four lines representing Placebo-Baseline, Placebo-Week 28, Tirzepatide 15 mg-Baseline, and Tirzepatide 15 mg-Week 28. The graph is divided into 1st and 2nd phases and shows insulin increasing significantly over 120 minutes for Tirzepatide 15 mg-Week 28 compared to other groups.*

FDA Label Image

Figure 2 (Moun Uspi F2 V1)

A line graph showing the percentage of HbA1c over 40 weeks post-randomization for MOUNJARO at 5 mg, 10 mg, and 15 mg doses compared to Semaglutide 1 mg. The x-axis represents weeks post-randomization from 0 to 40, and the y-axis shows HbA1c percentage from 5.5% to 8.5%. The graph illustrates a decline in HbA1c for all treatments with final values around 5.9% to 6.4% at week 40.*

FDA Label Image

Figure (Moun Vial Ifu 1 V1)

Illustration of a vial for MOUNJARO (tirzepatide) injection showing the protective cap at the top and the rubber stopper located underneath the cap.*

FDA Label Image

Figure (Moun Vial Ifu 10 V1)

An instructional illustration showing a close-up of hands preparing a syringe by drawing liquid from a vial. The image depicts the syringe needle inserted into the vial with a large arrow indicating the direction of drawing medication into the syringe. This is relevant for subcutaneous injection preparation.*

FDA Label Image

Figure (Moun Vial Ifu 11 V1)

An instructional illustration showing a hand holding a vial and a syringe. The syringe is being inserted into the vial, with an arrow indicating the direction for drawing medication from the vial into the syringe.*

FDA Label Image

Figure (Moun Vial Ifu 12 V1)

An instructional illustration showing a hand holding a syringe with a needle inserted into the forearm for subcutaneous injection. A separate close-up view of the syringe barrel displays volume markings from 0.1 to 0.6 mL. A downward arrow above the syringe indicates the direction for injection.*

FDA Label Image

Figure (Moun Vial Ifu 13 V1)

An instructional illustration showing two hands preparing an injection with a syringe and vial. One hand holds the vial upside down while the other pulls back the syringe plunger, drawing liquid into the syringe. The image demonstrates the preparation of an injectable medication dose.*

FDA Label Image

Figure (Moun Vial Ifu 14 V1)

An instructional illustration showing hands drawing medication from a vial into a syringe, with a close-up inset of the syringe barrel indicating volume markings from 0.1 to 0.5 mL.*

FDA Label Image

Figure (Moun Vial Ifu 15 V1)

An instructional illustration showing a hand holding a vial and another hand holding a syringe angled toward the vial. An arrow indicates the motion of inserting the syringe needle into the vial, demonstrating how to draw medication from the vial into the syringe.*

FDA Label Image

Figure (Moun Vial Ifu 16 V1)

An anatomical illustration showing injection site locations on a human figure for subcutaneous administration. Highlighted areas include the abdomen and outer thighs, indicating appropriate sites for injection.*

FDA Label Image

Figure (Moun Vial Ifu 17 V1)

An anatomical illustration showing the recommended injection sites on the outer upper arms for a subcutaneous injection. The image depicts a rear view of a human figure with shaded areas on both outer upper arms, indicating where the injection solution can be administered.*

FDA Label Image

Figure (Moun Vial Ifu 18 V1)

An instructional line drawing showing a person administering a subcutaneous injection with a syringe into the abdominal area, demonstrating the injection technique for MOUNJARO (tirzepatide) injection solution.*

FDA Label Image

Figure (Moun Vial Ifu 19 V1)

An instructional illustration showing a hand administering a subcutaneous injection into the abdominal area, with the other hand lifting the skin. The image depicts the injection technique for a solution delivered via a syringe, indicating the proper site and method for subcutaneous injection.*

FDA Label Image

Figure (Moun Vial Ifu 2 V1)

An instructional diagram of a syringe assembly showing labeled parts: Needle Shield, Needle, Plunger Tip, Plunger, and Syringe Body. The syringe body has volume markings from 0 to 1 mL, highlighted at 0.5 mL with a zoomed-in view for precise dosage indication.*

FDA Label Image

Figure (Moun Vial Ifu 20 V1)

An instructional line drawing showing a person administering an injection to the neck region using a syringe. The hand is holding the syringe at an angle with an arrow indicating the direction of injection.*

FDA Label Image

Figure (Moun Vial Ifu 3 V1)

An instructional illustration showing hands removing a protective cap from a vial, likely demonstrating the first step in preparing an injection. The image focuses on proper handling technique to access the vial's rubber stopper.*

FDA Label Image

Figure (Moun Vial Ifu 4 V1)

An instructional illustration showing a hand holding a vial of medication with the other hand peeling off the vial's protective cap, demonstrating how to prepare the vial for use.*

FDA Label Image

Figure (Moun Vial Ifu 5 V1)

An instructional illustration showing hands peeling back the protective cover from a syringe, likely related to preparation for injection. The syringe is partially visible, including the plunger and barrel with volume markings.*

FDA Label Image

Figure (Moun Vial Ifu 6 V1)

An instructional illustration showing hands peeling a protective cover off a small medical device or component, likely related to preparation of an injectable solution for subcutaneous use.*

FDA Label Image

Figure (Moun Vial Ifu 7 V1)

An illustration showing a medication vial with a cap being removed or lifted, with an arrow indicating the direction to pull the cap off. This diagram likely instructs how to open the vial before use.*

FDA Label Image

Figure (Moun Vial Ifu 8 V1)

An instructional illustration showing two hands holding a prefilled injection pen. The left hand is removing a cap or protective cover from the injection pen, with an arrow indicating the direction of removal to the left.*

FDA Label Image

Figure (Moun Vial Ifu 9 V1)

Instructional illustration showing a hand holding a syringe for subcutaneous injection. The image depicts aligning or pressing the syringe plunger, with a detailed inset of the syringe barrel marked with measurement increments from 0.1 to 0.5 mL.*

FDA Label Image

Figure (Moun Vial Md Ifu 14 V1)

An instructional illustration showing hands drawing liquid from a vial into a syringe. The syringe magnified inset highlights volume markings from 0.1 to 0.6 mL, indicating measurement precision during medication preparation.*

FDA Label Image

Figure (Moun Vial Md Ifu 2 V1)

Illustration of a syringe used for subcutaneous injection showing labeled parts including needle shield, needle, syringe body with volume markings from 0.1 to 1.0 mL, plunger tip, and plunger. A magnified inset details the 0.5 to 0.7 mL volume markings on the syringe barrel.*

FDA Label Image

Figure (Moun Vial Md Ifu 9 V1)

An instructional illustration showing two hands holding a syringe with measurement markings from 0.1 to 0.6, demonstrating the downward pressing motion on the syringe plunger. This likely depicts the step of expelling air or preparing the dose in a subcutaneous injection syringe.*

FDA Label Image

Figure (Mounjaro Kp 1 Pen V1)

The image shows a MOUNJARO injection pen for tirzepatide, 2.5 mg per 0.5 mL, used for subcutaneous administration. The pen is predominantly white with a gray grip and a purple dial at the end displaying the dose. It is labeled by A-S Medication Solutions.*

FDA Label Image

Figure (Mounjaro Kp 10 Dial Clicks V1)

An instructional diagram showing a hand peeling or lifting a protective seal or label from a small rectangular device or package. The image suggests a step in the process of preparing or using a medication product, likely related to MOUNJARO injection.*

FDA Label Image

Figure (Mounjaro Kp 11 Dial Zoom V1)

MOUNJARO 2.5 mg/0.5 mL injection, solution for subcutaneous use, label from A-S Medication Solutions. The image shows the product's vial label with active ingredient tirzepatide and strength information clearly displayed. NDC 50090-8025 is indicated on the label.*

FDA Label Image

Figure (Mounjaro Kp 12 Tap V1)

An instructional illustration showing a hand holding a syringe-like device, with another hand's index finger positioned to flick or tap the device. A red arrow points leftwards, indicating the direction or action to be performed on the device.*

FDA Label Image

Figure (Mounjaro Kp 13 5sec Hold V1)

An instructional illustration showing a hand holding a MOUNJARO (tirzepatide) injection pen with an arrow pointing upward, indicating the direction to pull. An inset shows a close-up of the pen needle tip, and a stopwatch icon suggests timing or waiting during preparation for subcutaneous injection.*

FDA Label Image

Figure (Mounjaro Kp 14 Zero Dial Zoom V1)

The packaging label for MOUNJARO 2.5 mg/.5 mL injection, a subcutaneous solution by A-S Medication Solutions. The label includes the proprietary name MOUNJARO prominently in large font, the dosage strength 2.5 mg/.5 mL, the generic name tirzepatide, and a depiction of the single-dose pen device with a gray body and orange tip. Additional text includes storage and handling information and the NDC number 50090-8025.*

FDA Label Image

Figure (Mounjaro Kp 15 Inj Sites V1)

An anatomical illustration showing recommended subcutaneous injection sites for an injection solution. The highlighted areas include the abdomen around the navel, outer thighs, and the back of the upper arms, indicating common locations for self-administered subcutaneous injections.*

FDA Label Image

Figure (Mounjaro Kp 16 Dial 1 Dose V1)

Instructional illustration showing a hand dialing the dose on a MOUNJARO (tirzepatide) injection pen. The image demonstrates adjusting the dose by turning the dial on the subcutaneous injection device.*

FDA Label Image

Figure (Mounjaro Kp 17 Dial 1 Zoom V1)

MOUNJARO 2.5 mg/0.5 mL injection, solution for subcutaneous use, labeled by A-S Medication Solutions. The image shows a single vial with printed dosage strength and product name visible on the label.*

FDA Label Image

Figure (Mounjaro Kp 18 Insert Needle V1)

An instructional illustration showing a hand holding an injection pen device, positioned to administer a subcutaneous injection into the abdomen. A red arrow indicates the direction of injection into the skin.*

FDA Label Image

Figure (Mounjaro Kp 19 Push Hold V1)

An instructional illustration showing how to administer a subcutaneous injection using a pen device. The image depicts a hand holding the injection device against the skin with an arrow indicating to push the button, accompanied by a timer symbol and text instructing to hold the push for 5 seconds.*

FDA Label Image

Figure (Mounjaro Kp 2 Pen Parts V2)

An illustrated diagram showing the parts of a MOUNJARO (tirzepatide) injection pen, including the pen cap with clip, cartridge with red inner seal, cartridge holder, plunger, pen body with label, dose indicator visible through the dose window, and dose knob. The pen needle parts are also illustrated separately, including the outer needle shield, inner needle shield, needle, and paper tab, with a note that needles are not included.*

FDA Label Image

Figure (Mounjaro Kp 20 Remove V1)

An instructional illustration showing a hand holding a prefilled injection pen near a person's abdomen with an arrow pointing to the left, indicating the direction for administering a subcutaneous injection.*

FDA Label Image

Figure (Mounjaro Kp 21 Cotton Ball V1)

An instructional illustration showing a hand pinching the skin around the abdominal area to prepare for a subcutaneous injection, indicated by a red arrow pointing to the injection site.*

FDA Label Image

Figure (Mounjaro Kp 22 Recap Shield V1)

An instructional illustration showing a hand removing a cap from a subcutaneous injection pen, indicated by an arrow pointing away from the pen tip. The image demonstrates how to prepare the injection device by taking off the protective cap before use.*

FDA Label Image

Figure (Mounjaro Kp 23 Remove Needle V1)

An instructional line drawing showing a hand removing a protective cap from the top of a pen-style injection device, with an arrow indicating the cap is being pulled off. This likely illustrates preparation steps for the MOUNJARO (tirzepatide) subcutaneous injection device.*

FDA Label Image

Figure (Mounjaro Kp 24 Recap Pen V1)

An instructional illustration showing the removal of a protective cap from a prefilled injection pen by pulling it straight off, indicated by a red arrow pointing away from the pen.*

FDA Label Image

Figure (Mounjaro Kp 3 Wash V1)

An instructional illustration showing two hands washing with soap bubbles, indicating hand hygiene practice.*

FDA Label Image

Figure (Mounjaro Kp 4 Uncap V1)

An instructional diagram showing a subcutaneous injection pen or syringe with a protective cap. The image highlights the removal of the cap by pulling it off in the direction indicated by a red arrow pointing left.*

FDA Label Image

Figure (Mounjaro Kp 5 Wipe V1)

An illustration showing a pair of hands cleaning the rubber top of a medication vial with a cloth or wipe, indicated by a red arrow, suggesting preparation of the vial for use.*

FDA Label Image

Figure (Mounjaro Kp 6 New Needle Tab V1)

An instructional illustration showing a hand lifting a protective cap from a needle or injection pen with a red arrow indicating an upward movement. This diagram likely demonstrates a step in preparing an injection device for subcutaneous use.*

FDA Label Image

Figure (Mounjaro Kp 7 Attach Needle V1)

An instructional diagram showing how to twist and remove the cap from a pen injector device. The image depicts a close-up of a pen, with red arrows indicating the direction to twist the cap off.*

FDA Label Image

Figure (Mounjaro Kp 8 Outer Shield V1)

An instructional illustration showing a close-up of a syringe with a needle cap being removed by pulling it straight upward, indicated by a red arrow above the cap.*

FDA Label Image

Figure (Mounjaro Kp 9 Inner Shield V1)

An instructional diagram showing the removal of a needle cap from a syringe or injection pen. The needle is attached to the top of the device, with an upward red arrow indicating the direction to pull the cap off before use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.